Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 653

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 9B
Chunk 653
---
 (a)) 
  
    Plan Category 
    (a)  
    (b)  
    (c) 
  
    Equity compensation plans approved by shareholders 

     2,121 
  
    Options to purchase common stock 
     666  
    $1.43  

    Restricted stock units and performance stock units 
     12,013  
     -  

    Equity compensation plans not approved by shareholders 
     -  
     -  
     - 
  
    Total 
     12,679  
        
     2,121 

The
other information required by this Item 12 of Form 10-K will be included under the caption “Information about MicroVision Common
Stock” in our 2025 Proxy Statement and is incorporated herein by reference.

61

ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

The
information required by this Item 13 of Form 10-K will be included under the captions “Certain Relationships and Related Transactions”
and “Board of Directors & Governance Matters” in our 2025 Proxy Statement and are incorporated herein by reference.

ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The
information required by this Item 14 of Form 10-K will be included under the caption “Independent Registered Public Accounting
Firm” in our 2025 Proxy Statement and is incorporated herein by reference.

PART
IV.

ITEM
15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(A)
Documents filed as part of this Annual Report on Form 10-K:

1.
Consolidated Financial Statements

●Report
                                            of Independent Registered Public Accounting Firm

●Consolidated
                                            Balance Sheets as of December 31, 2024 and 2023

●Consolidated
                                            Statements of Operations for the years ended December 31, 2024, 2023 and 2022

●Consolidated
                                            Statements of Comprehensive Loss for the years ended December 31, 2024, 2023 and 2022

●Consolidated
                                            Statements of Shareholders’ Equity for the years ended December 31, 2024,
                                            2023 and 2022

●Consolidated
                                            Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022

●Notes
                                            to Consolidated